Table 1 – Types of vertigo (non-exhaustive list)[/caption]
Vomiting
In older people, dizziness significantly increases the risk of falls.7 Implementing appropriate interventions to address modifiable risk factors such as dizziness is of paramount importance. In cases of drug-induced dizziness, deprescribing can be considered if the medicine can be safely reduced, discontinued or substituted to prevent inappropriate prescribing cascades of potentially inappropriate medicines (PIM), especially in the context of older people.29
A national education program for pharmacists funded by the Australian Government under the Quality Use of Diagnostics, Therapeutics and Pathology program.[/caption]
The hypothalamus houses neurons that produce neuropeptides called orexin A and B, which were discovered in 1998, and represent one of the most exciting discoveries in sleep medicine.5,13–15 Orexin-producing neurons help us stay awake and alert, especially when we really need to focus, which is critical for survival.5,14 These neurons reach out to many brain areas that use other wakefulness messengers such as acetylcholine, dopamine, histamine, serotonin and noradrenaline. These areas ‘talk back’ to the hypothalamus, to further boost wakefulness signals.5 Similarly, the thalamus is an important region that also serves to relay wakefulness signals from the RAS.5
Another dual orexin receptor antagonist (DORA), vornorexant*, is under development and currently undergoing clinical trials.28 
Other medicines such as dimdazenil* (partial positive allosteric modulator at GABAA specific to alpha-1 and alpha-5 GABAA receptor subtypes)41 and zuranolone* (positive allosteric modulator for GABAA) have also been tested, with positive outcomes in trials. Zuranolone* is marketed overseas specifically for postnatal depression, but clinical trials for its use in insomnia are ongoing.40
Kristy Carter (she/her)
Louise Edwards (she/her) Making carers visible in healthcare
Carers are frontline healthcare partners. Here's how pharmacists can recognise and empower them to transform patient care.
Young sparks light up pharmacy future
The future of pharmacy is bright, engaged and passionate, the search for the latest PSA MIMS Intern Pharmacist of the Year has revealed.
Judges were...
Visionary pharmacist named year’s best at PSA18
John Jackson FPS has been named PSA Pharmacist of the Year for his decades-long commitment to developing new practice and funding models, and for...
Pharmacists’ vaccination value adds up to saved lives
Federal Health Minister Greg Hunt has praised pharmacists’ role in saving lives through expanded vaccinations in community pharmacies, and undertaken to pressure states to...
Digital Health CRC to put focus on future of pharmacy
Pharmacists are being encouraged to look at the potential benefits digital technology will bring to the profession in the coming years.
Professor Libby Roughead, from...
How can community pharmacists make a difference in mental health?
Early detection
Community pharmacists can play a role in detecting warning signs for people experiencing a mental health problem. This can often be done through...
